| 臺大學術典藏 |
2020-03-05T07:52:37Z |
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses
|
Shih I.-M.; Wang T.-L.; Levine D.A.; Kurman R.J.; Olvera N.; Shaw P.; Clarke B.; Nakayama K.; KUAN-TING KUO; Wei L.; Roden R.B.S.; Yuan X.; Song L.; Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y. |
| 臺大學術典藏 |
2020-03-05T07:52:35Z |
Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma
|
Mao T.-L.; Ardighieri L.; Ayhan A.; KUAN-TING KUO; Wu C.-H.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-03T03:06:51Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Wen-Yih Tseng;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:07Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.; Wang T.-L.; Shih I.-M.; Hsieh C.-Y.; Tseng W.-Y.I.; Su Y.-N.; Lee C.-N.; Chen C.-A.; Chai C.-Y.; Hung C.-F.; WEN-FANG CHENG; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C. |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L;Shih I.-M;Hsieh C.-Y;Tseng W.-Y.I;Su Y.-N;CHIEN-NAN LEE;Chen C.-A;Chai C.-Y;Hung C.-F;Cheng W.-F; Cheng W.-F; Hung C.-F; Chai C.-Y; Chen C.-A; CHIEN-NAN LEE; Su Y.-N; Tseng W.-Y.I; Hsieh C.-Y; Shih I.-M; Wang T.-L; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:24Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L.;Shih I.-M.;Hsieh C.-Y.;Tseng W.-Y.I.;Su Y.-N.;Lee C.-N.;Chen C.-A.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chi-An Chen;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2017 |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
|
Wang T.-L.; Shih I.-M.; Sugimura H.; TSUI-LIEN MAO; Bahadirli-Talbott A.; Ogawa H.; Wu R.-C.; Kuhn E.; Ayhan A.; Ayhan A.;Kuhn E.;Wu R.-C.;Ogawa H.;Bahadirli-Talbott A.;Tsui-Lien Mao;Sugimura H.;Shih I.-M.;Wang T.-L. |
| 國立臺灣大學 |
2015 |
INCREASED PROLIFERATION IN AH/EIN WITH CONCURRENT INACTIVATION OF ARID1A AND PTEN TUMOR SUPPRESSORS
|
Ayhan, A.; Mao, T. L.; Rahmanto, Y. Suryo; Zeppernix, F.; Wu, R. C.; Wang, T. L.; Shih, I. M.; 毛翠蓮 |
| 臺大學術典藏 |
2015 |
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
|
Ayhan A.; TSUI-LIEN MAO; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2012 |
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
|
Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2010 |
Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma
|
Shih I.-M.; Yano T.; Taketani Y.; Fukayama M.; Nakagawa S.; Maeda D.; TSUI-LIEN MAO; Maeda D.;Tsui-Lien Mao;Fukayama M.;Nakagawa S.;Yano T.;Taketani Y.;Shih I.-M. |
| 臺大學術典藏 |
2009 |
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
|
Köbel M.; Xu H.; Gilks C.B.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D. |
| 臺大學術典藏 |
2009 |
Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas
|
KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2009 |
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma
|
KUAN-TING KUO; Mao T.-L.; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2009 |
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
|
Vasoontara C.; Bristow R.E.; Kurman R.J.; Shih I.-M.; Giuntoli R.L.; TSUI-LIEN MAO; Kuhajda F.P.; Ueda S.M. |
| 國立成功大學 |
2008-11 |
Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis
|
Tsai, Hung-Wen; Lin, C. P.; Chou, C. Y.; Li, C. F.; Chow, Nan-Haw; Shih, I. M.; Ho, Chung-Liang |
| 國立臺灣大學 |
2007 |
Immunohistochemistry of Choriocarcinoma V An Aid in Differential Diagnosis and in Elucidating Pathogenesis.
|
Mao, T-L; Kurman, RJ; Huang, C-C; Lin, M-C; Shih, I-M |
